“…There are numerous reports on nanoparticles (NPs) synthesis, but rarely do they mention the scalability and/or reproducibility to make large-scale synthesis plausible, making these two factors the main roadblocks in bringing nanomedicine to the patient. Iron oxide, in particular its nanosized counterpart, is one such material that has been revolutionizing several different industries such as sensor components, [1][2][3] contrast/imaging agents, [4][5][6][7][8][9][10] targeted drug delivery, [11][12][13][14] magnetic nanoprobes, 15 nanocatalysts 16,17 and magnetically responsive materials. 18,19 In the field of medicine, iron oxide nanoparticles (IONPs) hold an advantageous place due to their non-toxic nature, biocompatibility, relative ease of functionalization, and, in some cases, their ability to act as magnetic hyperthermia mediators.…”